Cite
Bortolomeazzi M, Keddar MR, Montorsi L, et al. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts. Gastroenterology. 2021;161(4):1179-1193doi: 10.1053/j.gastro.2021.06.064.
Bortolomeazzi, M., Keddar, M. R., Montorsi, L., Acha-Sagredo, A., Benedetti, L., Temelkovski, D., Choi, S., Petrov, N., Todd, K., Wai, P., Kohl, J., Denner, T., Nye, E., Goldstone, R., Ward, S., Wilson, G. A., Al Bakir, M., Swanton, C., John, S., Miles, J., Larijani, B., Kunene, V., Fontana, E., Arkenau, H. T., Parker, P. J., Rodriguez-Justo, M., Shiu, K. K., Spencer, J., & Ciccarelli, F. D. (2021). Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts. Gastroenterology, 161(4), 1179-1193. https://doi.org/10.1053/j.gastro.2021.06.064
Bortolomeazzi, Michele, et al. "Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts." Gastroenterology vol. 161,4 (2021): 1179-1193. doi: https://doi.org/10.1053/j.gastro.2021.06.064
Bortolomeazzi M, Keddar MR, Montorsi L, Acha-Sagredo A, Benedetti L, Temelkovski D, Choi S, Petrov N, Todd K, Wai P, Kohl J, Denner T, Nye E, Goldstone R, Ward S, Wilson GA, Al Bakir M, Swanton C, John S, Miles J, Larijani B, Kunene V, Fontana E, Arkenau HT, Parker PJ, Rodriguez-Justo M, Shiu KK, Spencer J, Ciccarelli FD. Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts. Gastroenterology. 2021 Oct;161(4):1179-1193. doi: 10.1053/j.gastro.2021.06.064. Epub 2021 Jun 29. PMID: 34197832; PMCID: PMC8527923.
Copy
Download .nbib